img

Global CD244 (2B4) Antibody Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CD244 (2B4) Antibody Market Insights, Forecast to 2034

CD244 (2B4) Antibody is an antibody directed against the CD244 protein in the human immune system.
Market Analysis and InsightsGlobal CD244 (2B4) Antibody Market
Global CD244 (2B4) Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CD244 (2B4) Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
CD244 is a cell surface molecule that belongs to the immunoglobulin superfamily and is mainly expressed on natural killer cells, T cells and certain subsets of B cells. By binding to the CD244 molecule, this antibody can regulate the activation, proliferation and function of immune cells, thereby affecting the regulation and effect of the immune response. Since CD244 plays an important role in regulating immune cell interactions, the potential application of CD244 antibodies in immunotherapy research and the treatment of tumors, autoimmune diseases and other diseases has attracted much attention.
Report Covers
This report presents an overview of global CD244 (2B4) Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global CD244 (2B4) Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sino Biological, Inc.
LifeSpan BioSciences, Inc
Thermo Fisher
BioLegend
Abbexa
Abcam
Cell Signaling Technology, Inc.
Arigo Biolaboratories Corp.
Boster Biological Technology
GeneTex
MyBiosource, Inc.
CUSABIO
Creative Diagnostics
Bio-Techne
AMSBIO
Segment by Type
Monoclonal Antibody
Polyclonal Antibody

Segment by Application


ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, CD244 (2B4) Antibody introduction, etc. CD244 (2B4) Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of CD244 (2B4) Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD244 (2B4) Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global CD244 (2B4) Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 ELISA
1.3.3 Western Blot
1.3.4 Immunofluorescence
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD244 (2B4) Antibody Market Perspective (2018-2029)
2.2 Global CD244 (2B4) Antibody Growth Trends by Region
2.2.1 CD244 (2B4) Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CD244 (2B4) Antibody Historic Market Size by Region (2018-2024)
2.2.3 CD244 (2B4) Antibody Forecasted Market Size by Region (2024-2029)
2.3 CD244 (2B4) Antibody Market Dynamics
2.3.1 CD244 (2B4) Antibody Industry Trends
2.3.2 CD244 (2B4) Antibody Market Drivers
2.3.3 CD244 (2B4) Antibody Market Challenges
2.3.4 CD244 (2B4) Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CD244 (2B4) Antibody by Players
3.1.1 Global CD244 (2B4) Antibody Revenue by Players (2018-2024)
3.1.2 Global CD244 (2B4) Antibody Revenue Market Share by Players (2018-2024)
3.2 Global CD244 (2B4) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CD244 (2B4) Antibody, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global CD244 (2B4) Antibody Market Concentration Ratio
3.4.1 Global CD244 (2B4) Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD244 (2B4) Antibody Revenue in 2022
3.5 Global Key Players of CD244 (2B4) Antibody Head office and Area Served
3.6 Global Key Players of CD244 (2B4) Antibody, Product and Application
3.7 Global Key Players of CD244 (2B4) Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD244 (2B4) Antibody Breakdown Data by Type
4.1 Global CD244 (2B4) Antibody Historic Market Size by Type (2018-2024)
4.2 Global CD244 (2B4) Antibody Forecasted Market Size by Type (2024-2029)
5 CD244 (2B4) Antibody Breakdown Data by Application
5.1 Global CD244 (2B4) Antibody Historic Market Size by Application (2018-2024)
5.2 Global CD244 (2B4) Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CD244 (2B4) Antibody Market Size (2018-2029)
6.2 North America CD244 (2B4) Antibody Market Size by Type
6.2.1 North America CD244 (2B4) Antibody Market Size by Type (2018-2024)
6.2.2 North America CD244 (2B4) Antibody Market Size by Type (2024-2029)
6.2.3 North America CD244 (2B4) Antibody Market Share by Type (2018-2029)
6.3 North America CD244 (2B4) Antibody Market Size by Application
6.3.1 North America CD244 (2B4) Antibody Market Size by Application (2018-2024)
6.3.2 North America CD244 (2B4) Antibody Market Size by Application (2024-2029)
6.3.3 North America CD244 (2B4) Antibody Market Share by Application (2018-2029)
6.4 North America CD244 (2B4) Antibody Market Size by Country
6.4.1 North America CD244 (2B4) Antibody Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CD244 (2B4) Antibody Market Size by Country (2018-2024)
6.4.3 North America CD244 (2B4) Antibody Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CD244 (2B4) Antibody Market Size (2018-2029)
7.2 Europe CD244 (2B4) Antibody Market Size by Type
7.2.1 Europe CD244 (2B4) Antibody Market Size by Type (2018-2024)
7.2.2 Europe CD244 (2B4) Antibody Market Size by Type (2024-2029)
7.2.3 Europe CD244 (2B4) Antibody Market Share by Type (2018-2029)
7.3 Europe CD244 (2B4) Antibody Market Size by Application
7.3.1 Europe CD244 (2B4) Antibody Market Size by Application (2018-2024)
7.3.2 Europe CD244 (2B4) Antibody Market Size by Application (2024-2029)
7.3.3 Europe CD244 (2B4) Antibody Market Share by Application (2018-2029)
7.4 Europe CD244 (2B4) Antibody Market Size by Country
7.4.1 Europe CD244 (2B4) Antibody Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CD244 (2B4) Antibody Market Size by Country (2018-2024)
7.4.3 Europe CD244 (2B4) Antibody Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CD244 (2B4) Antibody Market Size (2018-2029)
8.2 China CD244 (2B4) Antibody Market Size by Type
8.2.1 China CD244 (2B4) Antibody Market Size by Type (2018-2024)
8.2.2 China CD244 (2B4) Antibody Market Size by Type (2024-2029)
8.2.3 China CD244 (2B4) Antibody Market Share by Type (2018-2029)
8.3 China CD244 (2B4) Antibody Market Size by Application
8.3.1 China CD244 (2B4) Antibody Market Size by Application (2018-2024)
8.3.2 China CD244 (2B4) Antibody Market Size by Application (2024-2029)
8.3.3 China CD244 (2B4) Antibody Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia CD244 (2B4) Antibody Market Size (2018-2029)
9.2 Asia CD244 (2B4) Antibody Market Size by Type
9.2.1 Asia CD244 (2B4) Antibody Market Size by Type (2018-2024)
9.2.2 Asia CD244 (2B4) Antibody Market Size by Type (2024-2029)
9.2.3 Asia CD244 (2B4) Antibody Market Share by Type (2018-2029)
9.3 Asia CD244 (2B4) Antibody Market Size by Application
9.3.1 Asia CD244 (2B4) Antibody Market Size by Application (2018-2024)
9.3.2 Asia CD244 (2B4) Antibody Market Size by Application (2024-2029)
9.3.3 Asia CD244 (2B4) Antibody Market Share by Application (2018-2029)
9.4 Asia CD244 (2B4) Antibody Market Size by Region
9.4.1 Asia CD244 (2B4) Antibody Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CD244 (2B4) Antibody Market Size by Region (2018-2024)
9.4.3 Asia CD244 (2B4) Antibody Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Details
11.1.2 Sino Biological, Inc. Business Overview
11.1.3 Sino Biological, Inc. CD244 (2B4) Antibody Introduction
11.1.4 Sino Biological, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.1.5 Sino Biological, Inc. Recent Developments
11.2 LifeSpan BioSciences, Inc
11.2.1 LifeSpan BioSciences, Inc Company Details
11.2.2 LifeSpan BioSciences, Inc Business Overview
11.2.3 LifeSpan BioSciences, Inc CD244 (2B4) Antibody Introduction
11.2.4 LifeSpan BioSciences, Inc Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.2.5 LifeSpan BioSciences, Inc Recent Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher CD244 (2B4) Antibody Introduction
11.3.4 Thermo Fisher Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.3.5 Thermo Fisher Recent Developments
11.4 BioLegend
11.4.1 BioLegend Company Details
11.4.2 BioLegend Business Overview
11.4.3 BioLegend CD244 (2B4) Antibody Introduction
11.4.4 BioLegend Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.4.5 BioLegend Recent Developments
11.5 Abbexa
11.5.1 Abbexa Company Details
11.5.2 Abbexa Business Overview
11.5.3 Abbexa CD244 (2B4) Antibody Introduction
11.5.4 Abbexa Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.5.5 Abbexa Recent Developments
11.6 Abcam
11.6.1 Abcam Company Details
11.6.2 Abcam Business Overview
11.6.3 Abcam CD244 (2B4) Antibody Introduction
11.6.4 Abcam Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.6.5 Abcam Recent Developments
11.7 Cell Signaling Technology, Inc.
11.7.1 Cell Signaling Technology, Inc. Company Details
11.7.2 Cell Signaling Technology, Inc. Business Overview
11.7.3 Cell Signaling Technology, Inc. CD244 (2B4) Antibody Introduction
11.7.4 Cell Signaling Technology, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.7.5 Cell Signaling Technology, Inc. Recent Developments
11.8 Arigo Biolaboratories Corp.
11.8.1 Arigo Biolaboratories Corp. Company Details
11.8.2 Arigo Biolaboratories Corp. Business Overview
11.8.3 Arigo Biolaboratories Corp. CD244 (2B4) Antibody Introduction
11.8.4 Arigo Biolaboratories Corp. Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.8.5 Arigo Biolaboratories Corp. Recent Developments
11.9 Boster Biological Technology
11.9.1 Boster Biological Technology Company Details
11.9.2 Boster Biological Technology Business Overview
11.9.3 Boster Biological Technology CD244 (2B4) Antibody Introduction
11.9.4 Boster Biological Technology Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.9.5 Boster Biological Technology Recent Developments
11.10 GeneTex
11.10.1 GeneTex Company Details
11.10.2 GeneTex Business Overview
11.10.3 GeneTex CD244 (2B4) Antibody Introduction
11.10.4 GeneTex Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.10.5 GeneTex Recent Developments
11.11 MyBiosource, Inc.
11.11.1 MyBiosource, Inc. Company Details
11.11.2 MyBiosource, Inc. Business Overview
11.11.3 MyBiosource, Inc. CD244 (2B4) Antibody Introduction
11.11.4 MyBiosource, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.11.5 MyBiosource, Inc. Recent Developments
11.12 CUSABIO
11.12.1 CUSABIO Company Details
11.12.2 CUSABIO Business Overview
11.12.3 CUSABIO CD244 (2B4) Antibody Introduction
11.12.4 CUSABIO Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.12.5 CUSABIO Recent Developments
11.13 Creative Diagnostics
11.13.1 Creative Diagnostics Company Details
11.13.2 Creative Diagnostics Business Overview
11.13.3 Creative Diagnostics CD244 (2B4) Antibody Introduction
11.13.4 Creative Diagnostics Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.13.5 Creative Diagnostics Recent Developments
11.14 Bio-Techne
11.14.1 Bio-Techne Company Details
11.14.2 Bio-Techne Business Overview
11.14.3 Bio-Techne CD244 (2B4) Antibody Introduction
11.14.4 Bio-Techne Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.14.5 Bio-Techne Recent Developments
11.15 AMSBIO
11.15.1 AMSBIO Company Details
11.15.2 AMSBIO Business Overview
11.15.3 AMSBIO CD244 (2B4) Antibody Introduction
11.15.4 AMSBIO Revenue in CD244 (2B4) Antibody Business (2018-2024)
11.15.5 AMSBIO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD244 (2B4) Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global CD244 (2B4) Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CD244 (2B4) Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CD244 (2B4) Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CD244 (2B4) Antibody Market Share by Region (2018-2024)
Table 8. Global CD244 (2B4) Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CD244 (2B4) Antibody Market Share by Region (2024-2029)
Table 10. CD244 (2B4) Antibody Market Trends
Table 11. CD244 (2B4) Antibody Market Drivers
Table 12. CD244 (2B4) Antibody Market Challenges
Table 13. CD244 (2B4) Antibody Market Restraints
Table 14. Global CD244 (2B4) Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CD244 (2B4) Antibody Revenue Share by Players (2018-2024)
Table 16. Global Top CD244 (2B4) Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD244 (2B4) Antibody as of 2022)
Table 17. Global CD244 (2B4) Antibody Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by CD244 (2B4) Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of CD244 (2B4) Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD244 (2B4) Antibody, Product and Application
Table 21. Global Key Players of CD244 (2B4) Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CD244 (2B4) Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global CD244 (2B4) Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CD244 (2B4) Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CD244 (2B4) Antibody Revenue Share by Application (2018-2024)
Table 29. Global CD244 (2B4) Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CD244 (2B4) Antibody Revenue Share by Application (2024-2029)
Table 31. North America CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America CD244 (2B4) Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America CD244 (2B4) Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CD244 (2B4) Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CD244 (2B4) Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America CD244 (2B4) Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe CD244 (2B4) Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe CD244 (2B4) Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CD244 (2B4) Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CD244 (2B4) Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe CD244 (2B4) Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 46. China CD244 (2B4) Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 48. China CD244 (2B4) Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia CD244 (2B4) Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia CD244 (2B4) Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CD244 (2B4) Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CD244 (2B4) Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia CD244 (2B4) Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CD244 (2B4) Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 63. Sino Biological, Inc. Company Details
Table 64. Sino Biological, Inc. Business Overview
Table 65. Sino Biological, Inc. CD244 (2B4) Antibody Product
Table 66. Sino Biological, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 67. Sino Biological, Inc. Recent Developments
Table 68. LifeSpan BioSciences, Inc Company Details
Table 69. LifeSpan BioSciences, Inc Business Overview
Table 70. LifeSpan BioSciences, Inc CD244 (2B4) Antibody Product
Table 71. LifeSpan BioSciences, Inc Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 72. LifeSpan BioSciences, Inc Recent Developments
Table 73. Thermo Fisher Company Details
Table 74. Thermo Fisher Business Overview
Table 75. Thermo Fisher CD244 (2B4) Antibody Product
Table 76. Thermo Fisher Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 77. Thermo Fisher Recent Developments
Table 78. BioLegend Company Details
Table 79. BioLegend Business Overview
Table 80. BioLegend CD244 (2B4) Antibody Product
Table 81. BioLegend Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 82. BioLegend Recent Developments
Table 83. Abbexa Company Details
Table 84. Abbexa Business Overview
Table 85. Abbexa CD244 (2B4) Antibody Product
Table 86. Abbexa Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 87. Abbexa Recent Developments
Table 88. Abcam Company Details
Table 89. Abcam Business Overview
Table 90. Abcam CD244 (2B4) Antibody Product
Table 91. Abcam Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 92. Abcam Recent Developments
Table 93. Cell Signaling Technology, Inc. Company Details
Table 94. Cell Signaling Technology, Inc. Business Overview
Table 95. Cell Signaling Technology, Inc. CD244 (2B4) Antibody Product
Table 96. Cell Signaling Technology, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 97. Cell Signaling Technology, Inc. Recent Developments
Table 98. Arigo Biolaboratories Corp. Company Details
Table 99. Arigo Biolaboratories Corp. Business Overview
Table 100. Arigo Biolaboratories Corp. CD244 (2B4) Antibody Product
Table 101. Arigo Biolaboratories Corp. Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 102. Arigo Biolaboratories Corp. Recent Developments
Table 103. Boster Biological Technology Company Details
Table 104. Boster Biological Technology Business Overview
Table 105. Boster Biological Technology CD244 (2B4) Antibody Product
Table 106. Boster Biological Technology Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 107. Boster Biological Technology Recent Developments
Table 108. GeneTex Company Details
Table 109. GeneTex Business Overview
Table 110. GeneTex CD244 (2B4) Antibody Product
Table 111. GeneTex Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 112. GeneTex Recent Developments
Table 113. MyBiosource, Inc. Company Details
Table 114. MyBiosource, Inc. Business Overview
Table 115. MyBiosource, Inc. CD244 (2B4) Antibody Product
Table 116. MyBiosource, Inc. Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 117. MyBiosource, Inc. Recent Developments
Table 118. CUSABIO Company Details
Table 119. CUSABIO Business Overview
Table 120. CUSABIO CD244 (2B4) Antibody Product
Table 121. CUSABIO Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 122. CUSABIO Recent Developments
Table 123. Creative Diagnostics Company Details
Table 124. Creative Diagnostics Business Overview
Table 125. Creative Diagnostics CD244 (2B4) Antibody Product
Table 126. Creative Diagnostics Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 127. Creative Diagnostics Recent Developments
Table 128. Bio-Techne Company Details
Table 129. Bio-Techne Business Overview
Table 130. Bio-Techne CD244 (2B4) Antibody Product
Table 131. Bio-Techne Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 132. Bio-Techne Recent Developments
Table 133. AMSBIO Company Details
Table 134. AMSBIO Business Overview
Table 135. AMSBIO CD244 (2B4) Antibody Product
Table 136. AMSBIO Revenue in CD244 (2B4) Antibody Business (2018-2024) & (US$ Million)
Table 137. AMSBIO Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD244 (2B4) Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CD244 (2B4) Antibody Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global CD244 (2B4) Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CD244 (2B4) Antibody Market Share by Application: 2022 VS 2029
Figure 7. ELISA Case Studies
Figure 8. Western Blot Case Studies
Figure 9. Immunofluorescence Case Studies
Figure 10. Others Case Studies
Figure 11. CD244 (2B4) Antibody Report Years Considered
Figure 12. Global CD244 (2B4) Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global CD244 (2B4) Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global CD244 (2B4) Antibody Market Share by Region: 2022 VS 2029
Figure 15. Global CD244 (2B4) Antibody Market Share by Players in 2022
Figure 16. Global Top CD244 (2B4) Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD244 (2B4) Antibody as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by CD244 (2B4) Antibody Revenue in 2022
Figure 18. North America CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America CD244 (2B4) Antibody Market Share by Type (2018-2029)
Figure 20. North America CD244 (2B4) Antibody Market Share by Application (2018-2029)
Figure 21. North America CD244 (2B4) Antibody Market Share by Country (2018-2029)
Figure 22. United States CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CD244 (2B4) Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe CD244 (2B4) Antibody Market Share by Type (2018-2029)
Figure 26. Europe CD244 (2B4) Antibody Market Share by Application (2018-2029)
Figure 27. Europe CD244 (2B4) Antibody Market Share by Country (2018-2029)
Figure 28. Germany CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China CD244 (2B4) Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China CD244 (2B4) Antibody Market Share by Type (2018-2029)
Figure 36. China CD244 (2B4) Antibody Market Share by Application (2018-2029)
Figure 37. Asia CD244 (2B4) Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia CD244 (2B4) Antibody Market Share by Type (2018-2029)
Figure 39. Asia CD244 (2B4) Antibody Market Share by Application (2018-2029)
Figure 40. Asia CD244 (2B4) Antibody Market Share by Region (2018-2029)
Figure 41. Japan CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America CD244 (2B4) Antibody Market Share by Country (2018-2029)
Figure 51. Brazil CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries CD244 (2B4) Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Sino Biological, Inc. Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 58. LifeSpan BioSciences, Inc Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 59. Thermo Fisher Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 60. BioLegend Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 61. Abbexa Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 62. Abcam Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 63. Cell Signaling Technology, Inc. Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 64. Arigo Biolaboratories Corp. Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 65. Boster Biological Technology Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 66. GeneTex Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 67. MyBiosource, Inc. Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 68. CUSABIO Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 69. Creative Diagnostics Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 70. Bio-Techne Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 71. AMSBIO Revenue Growth Rate in CD244 (2B4) Antibody Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed